This article provides financial data specifically regarding the non-operating income (total) for Palantir Technologies Inc. Class A (BSESOF:PTX). It presents a table showing period, value, change, and change percentage, although the table itself is empty in the provided content. The page also includes various links related to TradingView's platform, market data, and company information.

BMO has been recognized for its Indigenous Bond and is partnering with Quantum Industry Canada and the Chicago Quantum Exchange on quantum technology and AI. These initiatives highlight BMO's focus on sustainable finance and advanced technology, offering investors a fresh perspective on the bank's valuation beyond its current share price and historical performance. The article suggests these developments provide important context for evaluating BMO against other financial institutions.

Benchmark Electronics, Inc. (NYSE: BHE) will release its first quarter fiscal year 2026 results on Wednesday, April 29, 2026, after the market closes. The company will also host a conference call on the same day at 5:00 p.m. Eastern Time to discuss these results. A live audio webcast and its replay will be available on the Benchmark Investor Relations website.

The article provides financial information specifically the net revenue of Banco Bilbao Vizcaya Argentaria, S.A. (BOY) traded on Gettex. It appears to be a stub or a section of a larger financial data page on TradingView, listing the period, value, and change in net revenue.

Microsoft stock is regaining strength, climbing 15% from its late-March lows, driven by positive sentiment regarding its AI spending. A recent Morgan Stanley CIO survey indicates Microsoft is a leader in generative AI and cloud migration, with strong prospects for increased software spending in 2026. Analyst Keith Weiss reiterated an Overweight rating and a $650 price target for MSFT, citing the company's strong competitive positioning in cloud workflows and GenAI.

Jennifer Piepszak, Chief Operating Officer of JPMorgan Chase & Co's Consumer & Community Banking, sold 9,136 shares of JPM on April 15, 2026. This transaction increased her total sales over the past year to 29,964 shares, with no purchases. JPMorgan Chase & Co stock is currently considered modestly overvalued with a price-to-GF-Value ratio of 1.2.

Chipmakers AMD, Arm Holdings, and Qualcomm have collectively invested $60 million in UK-based self-driving startup Wayve, extending its Series D funding round. This investment highlights the growing confidence in AI-powered mobility and advanced driver-assistance systems (ADAS), positioning these semiconductor firms at the forefront of AI-driven vehicle systems. Wayve's reliance on embodied AI and machine learning for scalable autonomous driving solutions aligns with the strategic interests of its new investors, and this partnership marks a significant convergence of hardware and software ecosystems in the evolving mobility landscape.

JPMorgan Chase & Co. (NYSE: JPM) has declared dividends on its Series DD, EE, GG, JJ, KK, LL, MM, and NN preferred stock, with information available on its Investor Relations website. The firm, a leading financial services provider with $4.9 trillion in assets as of March 31, 2026, operates globally in investment banking, consumer services, commercial banking, transaction processing, and asset management.

Artiva Biotherapeutics is focusing on rheumatoid arthritis (RA) as the primary indication for its off-the-shelf NK cell therapy, expecting to release efficacy data from at least 15 RA patients in the first half of the year. The company uses non-genetically modified NK cells in combination with rituximab to achieve deep B-cell depletion, targeting a 50% ACR50 response in late-line RA patients. Artiva also highlighted the therapy's safety profile, manufacturing scalability from single cord units, and its financial runway extended into Q2 2027.

Anglogold Ashanti PLC (AU) shares fell 4.8% to $104.47, a price significantly above its GF Value™ of $49.93, indicating it is overvalued by 109.2%. Despite a strong GF Score™ of 79/100, driven by growth and financial strength, its valuation score is notably low at 1/10, and there have been no insider transactions in the last three months. Investors are cautioned due to the narrow margin of safety and potential for downward adjustments.